Abstract
Objective and design
We investigated the role and regulation of zinc transporters in the activation of the inflammatory response in macrophages. Our exploratory computational study found that Zip14 (SLC39A14) was consistently up-regulated in activated macrophages; we therefore focused subsequently on that gene in the mechanistic study.
Material
The expression and function of Zip14 was assessed in primary macrophages obtained by in-vitro differentiation of monocytes from human blood.
Methods
Primary macrophages were subjected to treatments with lipopolysaccharides, cytokines, chemicals, and pharmacological agents. SLC39A14 and inflammatory cytokine gene expressions were assessed by RT-qPCR. Zip14 siRNA knockdown was performed to explore the gene function.
Results
Lipopolysaccharide’s inflammatory stimulus was a strong inducer of SLC39A14 mRNA expression in macrophages. This induction was dependent on calcium signaling, GC-rich DNA-binding, and NF-κB down-regulation. Impregnation of lipopolysaccharide-stimulated macrophages with the glucocorticoid dexamethasone further enhanced Zip14 expression while reducing interleukin-6 and tumor necrosis factor-α production. Zip14 knockdown in macrophages attenuated the expression and secretion of cytokines, indicating a buffering function for this zinc transporter.
Conclusions
Collectively, our results identified the zinc transporter Zip14 as expressed downstream of lipopolysaccharide signals in macrophages. Zip14 induction had a regulatory function in cytokine production.
Similar content being viewed by others
References
Calder PC, Kew S. The immune system: a target for functional foods? Br J Nutr. 2002;88(Suppl 2):S165–77.
Fabris N, Mocchegiani E. Zinc, human diseases and aging. Aging (Milano). 1995;7(2):77–93.
Leupold D, Poley JR, Meigel WN. Zinc therapy in acrodermatitis enteropathica. Helv Paediatr Acta. 1976;31(2):109–15.
Miller GG, Strittmatter WJ. Identification of human T cells that require zinc for growth. Scand J Immunol. 1992;36(2):269–77.
Provinciali M, Di Stefano G, Fabris N. Dose-dependent opposite effect of zinc on apoptosis in mouse thymocytes. Int J Immunopharmacol. 1995;17(9):735–44.
Truong-Tran AQ, Carter J, Ruffin RE, Zalewski PD. The role of zinc in caspase activation and apoptotic cell death. Biometals. 2001;14(3–4):315–30.
Koh JY, Suh SW, Gwag BJ, He YY, Hsu CY, Choi DW. The role of zinc in selective neuronal death after transient global cerebral ischemia. Science. 1996;272(5264):1013–6.
Vallee BL, Auld DS. Active zinc binding sites of zinc metalloenzymes. Matrix Suppl. 1992;1:5–19.
Nyborg JK, Peersen OB. That zincing feeling: the effects of EDTA on the behaviour of zinc-binding transcriptional regulators. Biochem J. 2004;381(Pt 3):e3–4.
Eide DJ. The SLC39 family of metal ion transporters. Pflugers Arch. 2004;447(5):796–800.
Liuzzi JP, Cousins RJ. Mammalian zinc transporters. Annu Rev Nutr. 2004;24:151–72.
Murgia C, Lang CJ, Truong-Tran AQ, Grosser D, Jayaram L, Ruffin RE, et al. Zinc and its specific transporters as potential targets in airway disease. Curr Drug Targets. 2006;7(5):607–27.
Begum NA, Kobayashi M, Moriwaki Y, Matsumoto M, Toyoshima K, Seya T. Mycobacterium bovis BCG cell wall and lipopolysaccharide induce a novel gene, BIGM103, encoding a 7-TM protein: identification of a new protein family having Zn-transporter and Zn-metalloprotease signatures. Genomics. 2002;80(6):630–45.
Liuzzi JP, Lichten LA, Rivera S, Blanchard RK, Aydemir TB, Knutson MD, et al. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci USA. 2005;102(19):6843–8.
Moshage H. Cytokines and the hepatic acute phase response. J Pathol. 1997;181(3):257–66.
Nolan JP. The role of intestinal endotoxin in liver injury: a long and evolving history. Hepatology. 2010;52(5):1829–35.
Matsumura T, Ito A, Takii T, Hayashi H, Onozaki K. Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. J Interferon Cytokine Res. 2000;20(10):915–21.
Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol. 2006;177(10):7303–11.
Buxade M, Lunazzi G, Minguillon J, Iborra S, Berga-Bolanos R, Del Val M, et al. Gene expression induced by Toll-like receptors in macrophages requires the transcription factor NFAT5. J Exp Med. 2012;209(2):379–93.
Altemeier WA, Matute-Bello G, Gharib SA, Glenny RW, Martin TR, Liles WC. Modulation of lipopolysaccharide-induced gene transcription and promotion of lung injury by mechanical ventilation. J Immunol. 2005;175(5):3369–76.
Hammer M, Mages J, Dietrich H, Servatius A, Howells N, Cato AC, et al. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J Exp Med. 2006;203(1):15–20.
Barish GD, Downes M, Alaynick WA, Yu RT, Ocampo CB, Bookout AL, et al. A nuclear receptor atlas: macrophage activation. Mol Endocrinol. 2005;19(10):2466–77.
Ahn SY, Cho CH, Park KG, Lee HJ, Lee S, Park SK, et al. Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression. Am J Pathol. 2004;164(5):1663–72.
Blume SW, Snyder RC, Ray R, Thomas S, Koller CA, Miller DM. Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest. 1991;88(5):1613–21.
Miller DM, Polansky DA, Thomas SD, Ray R, Campbell VW, Sanchez J, et al. Mithramycin selectively inhibits transcription of G-C containing DNA. Am J Med Sci. 1987;294(5):388–94.
Ray R, Snyder RC, Thomas S, Koller CA, Miller DM. Mithramycin blocks protein binding and function of the SV40 early promoter. J Clin Invest. 1989;83(6):2003–7.
Ray R, Thomas S, Miller DM. Mithramycin selectively inhibits the transcriptional activity of a transfected human c-myc gene. Am J Med Sci. 1990;300(4):203–8.
Snyder RC, Ray R, Blume S, Miller DM. Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. Biochemistry. 1991;30(17):4290–7.
Thastrup O. Role of Ca2(+)-ATPases in regulation of cellular Ca2+ signalling, as studied with the selective microsomal Ca2+-ATPase inhibitor, thapsigargin. Agents Actions. 1990;29(1–2):8–15.
Moore GA, McConkey DJ, Kass GE, O’Brien PJ, Orrenius S. 2,5-Di(tert-butyl)-1,4-benzohydroquinone–a novel inhibitor of liver microsomal Ca2+ sequestration. FEBS Lett. 1987;224(2):331–6.
Hakii H, Fujiki H, Suganuma M, Nakayasu M, Tahira T, Sugimura T, et al. Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanoylphorbol-13-acetate (TPA) type tumor promoter in two-stage mouse skin carcinogenesis. J Cancer Res Clin Oncol. 1986;111(3):177–81.
Jackson TR, Patterson SI, Thastrup O, Hanley MR. A novel tumour promoter, thapsigargin, transiently increases cytoplasmic free Ca2+ without generation of inositol phosphates in NG115-401L neuronal cells. Biochem J. 1988;253(1):81–6.
Myers JT, Swanson JA. Calcium spikes in activated macrophages during Fcgamma receptor-mediated phagocytosis. J Leukoc Biol. 2002;72(4):677–84.
Feher JJ, Lipford GB. Mechanism of action of ryanodine on cardiac sarcoplasmic reticulum. Biochim Biophys Acta. 1985;813(1):77–86.
Pian-Smith MC, Yada T, Yaney GC, Abdel el Motal SM, Wiedenkeller DE, Sharp GW. Mobilization of Ca2+ from intracellular stores of pancreatic beta-cells by the calcium store blocker TMB-8. Endocrinology. 1988;123(4):1984–91.
Takahashi M, Tanzawa K, Takahashi S. Adenophostins, newly discovered metabolites of Penicillium brevicompactum, act as potent agonists of the inositol 1,4,5-trisphosphate receptor. J Biol Chem. 1994;269(1):369–72.
Mattie M, Brooker G, Spiegel S. Sphingosine-1-phosphate, a putative second messenger, mobilizes calcium from internal stores via an inositol trisphosphate-independent pathway. J Biol Chem. 1994;269(5):3181–8.
Bates MD, Conn PM. Calcium mobilization in the pituitary gonadotrope: relative roles of intra- and extracellular sources. Endocrinology. 1984;115(4):1380–5.
Knoell DL, Liu MJ. Impact of zinc metabolism on innate immune function in the setting of sepsis. Int J Vitam Nutr Res. 2010;80(4–5):271–7.
Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006;13(5):816–25.
Bao S, Liu MJ, Lee B, Besecker B, Lai JP, Guttridge DC, et al. Zinc modulates the innate immune response in vivo to polymicrobial sepsis through regulation of NF-kappa B. Am J Physiol Lung Cell Mol Physiol. 2010;298(6):L744–54.
Bagley KC, Abdelwahab SF, Tuskan RG, Lewis GK. Calcium signaling through phospholipase C activates dendritic cells to mature and is necessary for the activation and maturation of dendritic cells induced by diverse agonists. Clin Diagn Lab Immunol. 2004;11(1):77–82.
Chow CW, Grinstein S, Rotstein OD. Signaling events in monocytes and macrophages. New Horiz. 1995;3(2):342–51.
Hoffmann A, Kann O, Ohlemeyer C, Hanisch UK, Kettenmann H. Elevation of basal intracellular calcium as a central element in the activation of brain macrophages (microglia): suppression of receptor-evoked calcium signaling and control of release function. J Neurosci. 2003;23(11):4410–9.
Smith JB, Herschman HR. Targeted identification of glucocorticoid-attenuated response genes: in vitro and in vivo models. Proc Am Thorac Soc. 2004;1(3):275–81.
Acknowledgments
This work was supported by the Biomedical Research Council, Agency for Science, Technology and Research, Singapore.
Author information
Authors and Affiliations
Corresponding author
Additional information
Responsible Editor: Liwu Li.
A. Sayadi and A.-T. Nguyen contributed equally to this work.
Rights and permissions
About this article
Cite this article
Sayadi, A., Nguyen, AT., Bard, F.A. et al. Zip14 expression induced by lipopolysaccharides in macrophages attenuates inflammatory response. Inflamm. Res. 62, 133–143 (2013). https://doi.org/10.1007/s00011-012-0559-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-012-0559-y